[ad_1]
Eton Pharmaceuticals ETON reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Eton Pharmaceuticals missed estimated earnings by 300.0%, reporting an EPS of $-0.06 versus an estimate of $0.03.
Revenue was up $4.29 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.13 which was followed by a 7.61% increase in the share price the next day.
Here’s a look at Eton Pharmaceuticals’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.13 | -0.14 | |
| EPS Actual | -0.21 | 0.04 | -0.24 | -0.10 |
| Revenue Estimate | 7.10M | 12.52M | 3.04M | 3.81M |
| Revenue Actual | 2.18M | 6.09M | 775K | 3.07M |
To track all earnings releases for Eton Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
[ad_2]
Image and article originally from www.benzinga.com. Read the original article here.